ASLN logo

ASLN Cash From Investing

Annual CFI

$268.50 K
-$146.20 K-35.25%

December 31, 2023

Summary

Performance

1-Year Change

-35.25%

3-Year Change

+29733.33%

5-Year Change

+101.16%

15-Year Change

+179.82%

ASLN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$414.70 K
ASLN annual cash flow from investing activities is currently -35.25% below its historical high of $414.70 thousand

3-Year Low

-$28.20 K

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ASLN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ASLN next annual earnings announcement has not yet been scheduled

OtherASLNcash flowmetrics:

Annual CFF

$10.72 M
ASLN annual cash flow from financing activities is $10.72 million

Annual CFO

-$46.64 M
ASLN annual cash flow from operations is -$46.64 million

Annual FCF

-$46.65 M
ASLN annual free cash flow is -$46.65 million

Annual CAPEX

$10.80 K
ASLN annual capital expenditures is $10.80 thousand

Quarterly CFI

N/A

March 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ASLN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7800.00
ASLN quarterly cash flow from investing activities is currently at an all-time high

3-Year Low

-
ASLN quarterly cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ASLN previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ASLN next earnings announcement has not yet been scheduled

OtherASLNcash flowmetrics:

Quarterly CFF

-
ASLN quarterly cash flow from financing activities value is unknown

Quarterly CFO

-
ASLN quarterly cash flow from operations value is unknown

Quarterly FCF

-
ASLN quarterly free cash flow value is unknown

Quarterly CAPEX

-
ASLN quarterly capital expenditures value is unknown

TTM CFI

N/A

March 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

ASLN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$43.30 K
ASLN TTM cash flow from investing activities is currently at an all-time high

3-Year Low

-
ASLN TTM cash flow from investing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ASLN previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ASLN next earnings announcement has not yet been scheduled

OtherASLNcash flowmetrics:

TTM CFF

-
ASLN TTM cash flow from financing activities value is unknown

TTM CFO

-
ASLN TTM cash flow from operations value is unknown

TTM FCF

-
ASLN TTM free cash flow value is unknown

TTM CAPEX

-
ASLN TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ASLN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-35.3%--
3 y3 years+10000.0%--
5 y5 years+101.2%--

ASLN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-35.3%-110.5%
5 y5-year-35.3%-110.5%
alltimeall time-35.3%-8701.2%

ASLAN Pharmaceuticals Limited Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2023
$268.50 K(-35.3%)
-
-
Dec 2022
$414.70 K(-1570.6%)
-
-
Dec 2021
-$28.20 K(-3233.3%)
-
-
Dec 2020
$900.00(-83.3%)
-
-
Dec 2019
$5400.00(-100.0%)
-
-
Dec 2018
-$23.09 M(+6765.1%)
-
-
Dec 2018
-
-$7800.00(-99.1%)
-$23.09 M(-0.0%)
Sep 2018
-
-$909.10 K(-91.0%)
-$23.10 M(+3.6%)
Jun 2018
-
-$10.08 M(-16.6%)
-$22.31 M(+80.5%)
Mar 2018
-
-$12.09 M(>+9900.0%)
-$12.36 M(+3573.5%)
Dec 2017
-$336.40 K
-
-
DateAnnualQuarterlyTTM
Dec 2017
-
-$14.70 K(-87.2%)
-$336.50 K(-27.8%)
Sep 2017
-
-$115.00 K(-16.1%)
-$465.90 K(-23.5%)
Jun 2017
-
-$137.00 K(+96.3%)
-$609.10 K(+10.7%)
Mar 2017
-
-$69.80 K(-51.6%)
-$550.00 K(+5.1%)
Dec 2016
-$523.50 K(+1205.5%)
-
-
Dec 2016
-
-$144.10 K(-44.2%)
-$523.50 K(+38.0%)
Sep 2016
-
-$258.20 K(+231.5%)
-$379.40 K(+213.0%)
Jun 2016
-
-$77.90 K(+79.9%)
-$121.20 K(+179.9%)
Mar 2016
-
-$43.30 K
-$43.30 K
Dec 2015
-$40.10 K(+22.6%)
-
-
Dec 2014
-$32.70 K
-
-

FAQ

  • What is ASLAN Pharmaceuticals Limited annual cash flow from investing activities?
  • What is the all time high annual CFI for ASLAN Pharmaceuticals Limited?
  • What is ASLAN Pharmaceuticals Limited annual CFI year-on-year change?
  • What is the all time high quarterly CFI for ASLAN Pharmaceuticals Limited?
  • What is the all time high TTM CFI for ASLAN Pharmaceuticals Limited?

What is ASLAN Pharmaceuticals Limited annual cash flow from investing activities?

The current annual CFI of ASLN is $268.50 K

What is the all time high annual CFI for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high annual cash flow from investing activities is $414.70 K

What is ASLAN Pharmaceuticals Limited annual CFI year-on-year change?

Over the past year, ASLN annual cash flow from investing activities has changed by -$146.20 K (-35.25%)

What is the all time high quarterly CFI for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high quarterly cash flow from investing activities is -$7800.00

What is the all time high TTM CFI for ASLAN Pharmaceuticals Limited?

ASLAN Pharmaceuticals Limited all-time high TTM cash flow from investing activities is -$43.30 K